| Title： | Expert Consensus on the Coordinated Development and Governance of Healthcare, Health Insurance, and Pharmaceuticals |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | Healthcare institutions, health insurance agencies, and professionals, managers, and researchers in the fields of healthcare and pharmaceuticals. |
| Evidence classification method： | Grade |
| Development unit： | Institute for Healthy China, Tsinghua University, and Healthy China Research Network. |
| Registration time: | 2024-08-26 |
| Registration number： | PREPARE-2024CN324 |
| Purpose of the guideline: | Focusing on promoting the coordinated development and governance of health insurance, healthcare, and pharmaceuticals is one of the key tasks in deepening the reform of the healthcare system. However, the connotations, objectives, content, and pathways of this coordinated development and governance are not yet clearly defined. Against this backdrop, the Institute for Healthy China at Tsinghua University and the Healthy China Research Network organized multidisciplinary experts from across the country. Based on a review of domestic and international literature and after multiple rounds of expert discussions, they aim to develop the "Expert Consensus on the Coordinated Development and Governance of Healthcare, Health Insurance, and Pharmaceuticals." This document includes the basic connotations, objectives, logical framework, principles, core elements, and recommended suggestions for the coordinated development and governance of healthcare, health insurance, and pharmaceuticals. The goal of this expert consensus is to provide expert advice and reference points to support the effective and scientifically sound implementation of coordinated development and governance in these areas. |
Latest registration
